Avoiding cardiopulmonary bypass during coronary artery bypass grafting (CABG) does not improve the clinical outcomes of low-risk patients, but it is more […]
The preliminary findings of this study suggest that the higher CQ dosage should not be recommended for critically ill patients with COVID-19 because of its potential safety hazards, especially when taken concurrently with azithromycin and oseltamivir. These findings cannot be extrapolated to patients with nonsevere COVID-19.